“Europe has traditionally large and strong chemical, food and consumer goods industries, and these have shown that they are very aware of the necessities and opportunities to change more and more to biotech enabled or biobased production and products. Perhaps there should be more that do so and it should be faster, reflecting the often-heard statement that Europe is good in science and not so good in upscaling and commercialization. Some of them point however to the more attractive business environments in for example the USA and Brazil, and act subsequently”. To say it in this long interview with Il Bioeconomista is Ernst Kloosterman, CEO of the Industrial Biotechnology Network Norway, a not-for-profit member association of organizations and individuals who want to stimulate to more research, knowledge transfer and innovation within the Norwegian biobased industry and industrial biotechnology sectors. With him we talk about the bioeconomy in Norway and Europe, with a look outside Europe.
Interview by Mario Bonaccorso